Law Offices of Howard G. Smith announces an investigation on behalf of investors of Illumina Inc. ("Illumina") or the "Company") (NASDAQ: ILMN) concerning the Company and its officers' possible violations of federal securities laws. On October 10, 2016 Illumina issued a press release announcing disappointing financial results for the third quarter of fiscal year 2016. Illumina had previously forecasted revenues of $625 to $630 million for the quarter, but citing "declining demand for its high-speed genetic sequences," the Company only generated $607 million. On this news, shares of Illumina were down as much as 25% during intraday trading on October 11, 2016. If you purchased Illumina securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.